Navigation Links
Global Pharmaceutical and Biotechnology Industry Boosts Confidence for Investors as the Market Expands

MOUNTAIN VIEW, Calif., July 27, 2015 /PRNewswire/ -- In recent years, the global pharmaceutical and biotechnology industry has outperformed other sectors in terms of stock market indices. The appeal of orphan drugs and systems that reduce the cost of healthcare will continue to attract investors to fund the industry.

Logo -

Analysis from Frost & Sullivan, Funding Patterns in the Global Pharma and Biotech Industry (, reveals the volume of venture capital (VC) deals fell by 41.2 percent between 2010 and 2014, while private equity (PE) deal volume declined by 23.4 percent. However, investors will become established within the pharmaceutical and biotech industry to avail long-term returns.

For complimentary access to more information on this research, please visit:

"Corporate investors expect to play a significant role in intensifying competition and replenishing the depleting drug pipeline," said Frost & Sullivan Senior Research Analyst Saneesh Edacherian. "The strong return of the initial public offering market in the U.S. is likely to further encourage Private Equity/Venture Capital investors, especially in the biotechnology sector."

Key trends within the pharmaceutical and biotech industry include:

  • The rise of market demand for drugs.
  • Governments striving to contain drug prices.
  • A decline in profitability of large pharmaceutical companies.
  • Firms experiencing patent expiries and revenue losses.
  • A decline of research & development by large pharmaceutical companies.

"Shrinking pipelines and increased cost pressures make mergers and acquisitions a lifeline for participants in the pharmaceuticals sector," noted Edacherian. "Mergers and acquisitions are either approached as an exit option for investors, or as a strategy for leading pharmaceutical companies to expand their capabilities in the global market."

Funding Patterns in the Global Pharma and Biotech Industry is part of the Business and Financial Services ( subscription. Frost & Sullivan's related studies include: Working Capital Management in the North American and European Pharmaceutical Industry, Mergers and Acquisitions in the Global Life and Health Insurance Industry and US Healthcare Real Estate Investment Trusts Industry. All studies included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan's Business and Financial Services group serves clients around the world in all aspects of financial analysis, market research and monitoring, due diligence, idea generation, opportunity analysis, investment valuation and other proprietary research.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Funding Patterns in the Global Pharma and Biotech Industry

Kayla Belcher
Corporate Communications – North America
P: 210.247.2450
F: 210.348.1003


SOURCE Frost & Sullivan
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Aptamers (DNA, RNA, XNA) Market 2015-2020 - End-User Analysis: Academic Research Institutes, Biotechnology & Pharmaceutical Companies & CRO
2. Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 Billion
3. Global Market for Wearable Devices 2015-2020
4. Global Cardiac Rhythm Management Device Markets 2015-2019
5. Global Neonatal Warming Equipment Market 2015-2019 - Key Vendors are Dragerwerk, Fisher & Paykel Healthcare, GE Healthcare, Philips Healthcare & Phoenix Medical Systems
6. Global Biosimilars Market Forecasts 2015-2020 - Analysis of the $2.2 Billion Industry
7. Global Contrast Media/Contrast Agents (Iodinated, Gadolinium, Barium, Microbubble) Market 2015 Forecasts and Trendsto 2020 for the $5.17 Billion Industry
8. Global Nuclear Medicine/Radiopharmaceuticals Market 2015-2020 - Potential Radioisotopes In The Pipeline a Huge Opportunity
9. iRhythm Technologies Appoints Marga Ortigas-Wedekind Executive Vice President, Global Marketing
10. Phytonutrients Market 2015 - Global Trends and Forecast to 2020 with FMC, BASF, Pharmachem Labs, DSM NV & Raisio Plc Dominating the $4 Billion Industry
11. Biophotonics - Global Strategic Business Report 2015 - Private Foundations Come Forth to Invest in Biophotonics
Post Your Comments:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):